InvestorsHub Logo
Followers 504
Posts 10140
Boards Moderated 0
Alias Born 04/28/2014

Re: None

Wednesday, 05/27/2015 3:04:31 PM

Wednesday, May 27, 2015 3:04:31 PM

Post# of 1253
$PTBI recent news/filings

bullish
high and tight flag breakout

reference
http://thepatternsite.com/htf.html

## source: finance.yahoo.com

Wed, 27 May 2015 12:03:00 GMT ~ PlasmaTech Biopharmaceuticals to Present at the 2015 Marcum MicroCap Conference

[Marketwired] - PlasmaTech Biopharmaceuticals, Inc. , a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announces today ...

read full: http://finance.yahoo.com/news/plasmatech-biopharmaceuticals-present-2015-marcum-120300443.html
*********************************************************

Tue, 26 May 2015 17:15:39 GMT ~ REMINDER: PlasmaTech Biopharmaceuticals First Quarter 2015 Conference Call Tomorrow

[Marketwired] - PlasmaTech Biopharmaceuticals, Inc. , a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, will provide ...

read full: http://finance.yahoo.com/news/reminder-plasmatech-biopharmaceuticals-first-quarter-171539579.html
*********************************************************

Fri, 22 May 2015 17:04:22 GMT ~ PLASMATECH BIOPHARMACEUTICALS INC Financials


read full: http://finance.yahoo.com/q/is?s=ptbi
*********************************************************

Wed, 20 May 2015 12:03:00 GMT ~ PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDA

[Marketwired] - PlasmaTech Biopharmaceuticals, Inc. , a biopharmaceutical company focused on gene therapy and plasma-based products for severe and life- threatening rare diseases announced today that the U.S. Food and ...

read full: http://finance.yahoo.com/news/plasmatech-biopharmaceuticals-announces-orphan-drug-120300783.html
*********************************************************

Mon, 18 May 2015 20:32:40 GMT ~ PLASMATECH BIOPHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistere


read full: http://biz.yahoo.com/e/150518/ptbi8-k.html
*********************************************************

$PTBI charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PTBI company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PTBI/company-info
Ticker: $PTBI
OTC Market Place: Not Available
CIK code: 0000318306
Company name: PlasmaTech Biopharmaceuticals, Inc.
Company website: http://www.accesspharma.com
Incorporated In: DE, USA

Business Description: Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the development and commercialization of proprietary products for the treatment and supportive care of cancer patients. Access has one approved product, two products in Phase 2 development, and five preclinical development programs. The company's approved product is MuGard(TM) for the management of oral mucositis (a common and debilitating side effect of many cancer therapies) for which marketing authorization has been allowed by the FDA. Access' ProLindac(TM), a polymer-linked platinum cancer drug is in Phase 2 clinical testing in cancer patients, as is Phenylbutyrate, a pleotropic agent which current evidence suggests acts as both an HDAC inhibitor and a differentiating agent. The Company's preclinical development programs include Angiolix, a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is potentially targeted to a number of tumor types, including breast and ovarian; Prodrax, a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill tumor cells; Alchemix, a chemotherapeutic agent that combines two modes of action to overcome drug resistance, and oral insulin, which utilizes the company's Cobalamin(TM) oral drug delivery technology.Less >>

$PTBI share structure

## source: otcmarkets.com

Market Value: $179,699,321 a/o May 26, 2015
Shares Outstanding: 19,988,801 a/o Mar 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01

$PTBI extra dd links

Company name: PlasmaTech Biopharmaceuticals, Inc.
Company website: http://www.accesspharma.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PTBI+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PTBI+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PTBI+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/news - http://finance.yahoo.com/q/h?s=PTBI+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PTBI/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PTBI+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PTBI
DTCC (dtcc.com): http://search2.dtcc.com/?q=PlasmaTech+Biopharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=PlasmaTech+Biopharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=PlasmaTech+Biopharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.accesspharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.accesspharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.accesspharma.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PTBI
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000318306&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PTBI&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PTBI
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PTBI+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PTBI+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PTBI
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PTBI
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PTBI+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PTBI/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PTBI+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PTBI.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PTBI
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PTBI/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PTBI/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PTBI
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PTBI
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PTBI:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PTBI
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PTBI



$PTBI DD Notes ~ http://www.ddnotesmaker.com/PTBI

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABEO News